Skip to main content
Food Safety

Mycotoxin Testing for Grains and Food Ingredients: What Aflatoxin and Ochratoxin Limits Mean for US Brands

Aflatoxins and ochratoxin A threaten grains, spices, and botanicals. Learn how food safety laboratories test for mycotoxins and what FDA compliance requires.

Nour Abochama Vice President of Operations, Qalitex Laboratories

Conclusión clave

Aflatoxins and ochratoxin A threaten grains, spices, and botanicals. Learn how food safety laboratories test for mycotoxins and what FDA compliance requires.

The USDA has estimated that mycotoxin contamination costs US agriculture between $932 million and $1.4 billion per year. That figure doesn’t include the product liability exposure, retail delistings, or brand damage that follows a confirmed contamination event — those costs are harder to quantify and often worse than the recall itself.

Aflatoxin alone has triggered more than 400 FDA import refusals annually in recent surveillance cycles, flagging shipments across commodities ranging from pistachios from Iran to dried chiles from Mexico. If your product line includes grains, tree nuts, dried fruits, spices, or botanical ingredient powders, mycotoxin testing is something you need a real program around — not just a checkbox on an incoming COA.

Under FSMA’s Preventive Controls for Human Food rule (21 CFR Part 117), you’re required to identify and evaluate mycotoxins as a chemical hazard if they are “known or reasonably foreseeable” given your raw material profile. For most grain-based and botanical products, that standard is met almost automatically. What’s less clear is which analytes to test, which method to specify, and what internal limits actually make sense. That’s where most food brands hit a wall.

What Aflatoxins and Ochratoxin A Actually Are

Mycotoxins are secondary metabolites produced by mold species — primarily Aspergillus, Fusarium, and Penicillium — under conditions of heat, humidity, and physiological stress during crop growth or post-harvest storage. They’re chemically stable and heat-resistant, meaning your cooking, roasting, or extrusion process won’t destroy them. Some are potent carcinogens or nephrotoxins at chronic low-dose exposure levels.

The two families you’ll encounter most frequently in US regulatory compliance work are:

Aflatoxins (B1, B2, G1, G2): Produced mainly by Aspergillus flavus and Aspergillus parasiticus, aflatoxin B1 is classified as a Group 1 carcinogen by the International Agency for Research on Cancer — the same classification assigned to benzene and asbestos. It’s the most potent naturally occurring hepatocarcinogen identified so far. FDA’s action level for total aflatoxins in human food is 20 ppb (parts per billion, equivalent to µg/kg). California Prop 65 lists aflatoxin B1 with a no significant risk level (NSRL) of just 0.02 µg per day, making it one of the most restrictively regulated substances under that statute.

Ochratoxin A (OTA): Produced primarily by Aspergillus ochraceus and Penicillium verrucosum, OTA is a nephrotoxin and probable human carcinogen (IARC Group 2B). FDA doesn’t maintain a specific numerical action level for OTA in most US food categories, but the EU’s Regulation 1881/2006 establishes limits ranging from 3 µg/kg in processed cereal products to 10 µg/kg in dried vine fruits like raisins. If you sell to EU buyers or export to European markets, OTA limits are commercially mandatory regardless of FDA’s current stance.

There are other mycotoxin families worth monitoring — fumonisins, deoxynivalenol (DON), zearalenone — but aflatoxins and OTA represent the bulk of US regulatory and commercial risk for the ingredient categories most food brands are actually using.

How FDA’s Regulatory Framework Works in Practice

FDA’s 20 ppb action level for total aflatoxins applies to corn, peanuts, peanut products, Brazil nuts, and other tree nuts and nut products for human food use. Finished consumer products are expected to comply with the same threshold.

Here’s the complication most brands miss: the 20 ppb action level is FDA’s enforcement threshold — not a safety target, and not the standard your preventive controls program should be built around. Under 21 CFR 117.135, you’re required to establish and validate critical limits for your control measures. Using the regulatory action level as your acceptance criterion means a supplier lot sitting at 18 ppb passes your incoming inspection but offers you almost no margin before a problem. Most defensible food safety programs set internal specifications of ≤10 ppb or ≤5 ppb total aflatoxins. Major retail buyers and co-manufacturers often require ≤5 ppb contractually.

FDA also maintains active import alerts that trigger automatic detention without physical examination. Import Alert 99-33 covers aflatoxin-contaminated corn from several countries. Import Alert 99-19 covers pistachios. Shipments subject to an automatic detention order can be held at the port of entry simply by being flagged in the prior notice system — no physical exam required. If your supply chain touches any of these commodities, supplier qualification testing through an accredited food safety laboratory isn’t a nice-to-have.

One more layer worth knowing: FDA’s Reportable Food Registry (21 CFR Part 417) requires you to report to FDA within 24 hours if you have reasonable probability that use of your article of food will cause serious adverse health consequences. Aflatoxin contamination discovered post-distribution can trigger a Reportable Food submission, not just a voluntary recall. That changes the risk calculus on how rigorous your incoming testing program needs to be.

The Testing Methods That Food Safety Laboratories Actually Use

Three methods are in routine commercial use, and they’re not interchangeable in terms of sensitivity, matrix performance, or regulatory weight.

ELISA Lateral Flow (Rapid Immunoassay): Fast, low-cost, and useful for high-volume screening at the point of receiving. Detection limits for aflatoxin with most commercial kits run 2–5 ppb, which is sufficient when the result is clearly negative. The limitation is specificity — immunoassay methods cross-react with structurally similar compounds in complex matrices and can produce false positives in spice or botanical powders. Any result above your trigger threshold needs confirmatory testing before you make a disposition decision. Lateral flow works well as a first pass; it doesn’t work well as a final answer.

HPLC with Fluorescence Detection (HPLC-FLD): The traditional regulatory gold standard for aflatoxin quantification. Paired with immunoaffinity column (IAC) cleanup to isolate analytes from interfering matrix components. AOAC Official Methods 990.33 and 991.31 use this approach and are widely accepted by FDA and third-party auditors. Detection limits routinely reach 0.1–0.5 ppb. The method has decades of validation data across commodity matrices, and its regulatory defensibility is as strong as any method available.

LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry): The current best practice for multitoxin panels. A single sample preparation and injection can simultaneously quantify aflatoxins B1/B2/G1/G2, ochratoxin A, fumonisins B1 and B2, DON, and zearalenone. Detection limits for aflatoxins with LC-MS/MS can reach 0.01–0.1 ppb, well below any applicable regulatory threshold. It’s also the preferred method for complex botanical matrices — turmeric, paprika, ashwagandha — where HPLC-FLD may encounter matrix interference that compromises accuracy. We run LC-MS/MS multitoxin panels at Qalitex specifically because testing each analyte separately via HPLC across a diverse botanical ingredient program doesn’t make operational or financial sense for most clients.

The method question matters more than brands typically realize. If your food safety laboratory is running ELISA-only screens on spice or botanical powder lots and calling that mycotoxin testing, the result isn’t wrong — it’s just not as sensitive or specific as the decision deserves.

Which Ingredient Categories Carry the Highest Risk

Not all ingredients need the same testing frequency or scrutiny. Aflatoxin and OTA prevalence varies meaningfully by commodity.

Corn and corn-derived ingredients: Domestic US corn carries modest aflatoxin risk in normal crop years, but drought conditions — increasingly frequent in Southern and Plains growing regions — can push field contamination well above 20 ppb. Corn sourced from parts of Central America, West Africa, and Southeast Asia shows the highest import rejection rates in FDA surveillance data.

Tree nuts — particularly peanuts, pistachios, almonds, and Brazil nuts: Peanuts are the textbook high-risk crop, with substantial storage-phase Aspergillus contamination risk. Brazil nuts have a structural disadvantage: their seed geometry creates natural pockets where moisture and mold colonization concentrate.

Dried fruits — figs, dates, raisins: Dried figs are among the most consistently contaminated commodities in global trade. EU RASFF (Rapid Alert System for Food and Feed) notifications show dried fig rejections for aflatoxin across multiple origin countries year over year. OTA in raisins is a well-documented issue under EU frameworks.

Spices — paprika, chili powder, black pepper, cayenne: RASFF data shows aflatoxin contamination in 15–20% of commercial paprika lots from certain origins. Powdered forms carry higher risk than whole dried spices because grinding distributes contamination from a single colonized particle throughout a larger mass.

Botanical ingredient powders — turmeric, ginger, ashwagandha, black seed: Used heavily in functional foods and dietary supplements, these ingredients often originate from international sources with variable post-harvest drying and storage practices. Both aflatoxin and OTA have shown up in commercial surveys of botanical powders at levels that warrant routine testing.

A critical note on sampling: mycotoxins distribute heterogeneously within a bulk lot. A contaminated kernel or cluster can sit adjacent to clean material, making point sampling unreliable. AOAC sampling procedures for mycotoxins specify composite sampling plans — typically 10-sample composites drawn from multiple positions across a lot — to achieve statistical representativeness. If a supplier COA shows mycotoxin results from a single grab sample of a 1,000 lb or larger lot, that’s worth flagging in your supplier review.

Building Mycotoxin Testing Into Your Food Safety Program

For food manufacturers working with grains, spices, or botanical ingredients, here’s where to start:

  1. Map your ingredient risk profile. Not every ingredient demands the same testing frequency. Corn-based ingredients, tree nuts, and spices warrant routine lot-by-lot testing. Lower-risk inputs like refined oils or synthetic flavor extracts probably don’t. A risk-based approach defined by commodity, origin, and historical COA data keeps costs proportionate.

  2. Set your internal limits before you start testing — not after. Don’t default to FDA’s 20 ppb action level as your pass/fail criterion. Build in margin. A ≤10 ppb or ≤5 ppb specification for total aflatoxins is more defensible in FDA audits and retail buyer reviews, and it protects you from borderline lots that could push finished product close to threshold during concentration.

  3. Specify the method in your supplier requirements. “Tested for aflatoxins” is not a complete requirement. Ask whether results come from ELISA screening or from confirmatory HPLC-FLD or LC-MS/MS. Ask about the sampling protocol used. Ask what the stated detection limit is. These details belong in your supplier specification agreement, not just in a purchase order note.

  4. Require testing from an accredited food safety laboratory. ISO 17025 accreditation means the laboratory’s methods have been independently assessed for technical competence, measurement uncertainty, and quality systems. Results from an accredited food safety laboratory carry significantly more regulatory weight than those from unaccredited commercial labs — and in an FDA investigation or litigation, that distinction is not academic.

The question your food safety program should answer isn’t just whether mycotoxin testing happened. It’s whether the method was sensitive enough, the sampling was representative, and the data came from a lab qualified to produce results you can actually stand behind.


Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Nour Abochama

Escrito y revisado por

Nour Abochama

Vice President of Operations, Qalitex Laboratories

Chemical engineer who has founded and sold three laboratories and a pharmaceutical company. 17+ years of experience in laboratory operations, quality assurance, and regulatory compliance. Master's in Biomedical Engineering from Grenoble INP – Ense3. Former Director of Quality at American Testing Labs and Labofine. Expert in FDA registration, Health Canada compliance, and ISO 17025 laboratory management. Executive Producer and co-host of the Nourify-Beautify Podcast.

Chemical Engineering17+ Years Lab OperationsISO 17025 ExpertFDA & Health Canada Compliance
Ver perfil de LinkedIn →
📋

Gratis: Lista de verificación de ensayos de suplementos

Todos los ensayos que su producto necesita antes de salir al mercado — desde identidad y potencia hasta metales pesados y microbiología.

Descargar la lista gratuita →

¿Necesita análisis de laboratorio?

Solicite presupuesto en nuestro laboratorio acreditado según ISO 17025. Resultados en 48 horas.

Solicitar presupuesto →